Luvo Health NAD+ prices
3 figures read September 2026.
Every NAD+ figure Luvo Health publishes is a floor — a “from” or “starting at” price, $27 at the bottom — so the number on the page is where its range begins and not necessarily a price anyone is charged.
What Luvo Health publishes
Luvo Health publishes only a floor — a “from” or “starting at” figure, which is the bottom of a range and not a price anyone is necessarily charged. Of the 29 sellers in this index that fall in the same bucket, that puts it with the 27% of the roster that publishes this shape of number rather than another one. A standing rate charged on a calendar month is the only figure this site treats as a monthly price, and 60 of the 106 sellers in this index — including this one — do not publish one.
The figure above is a from-price, “/week”. This site never prints a price without that qualifier, on any surface, because the same number means a different thing depending on it — and in this corpus the same seller often prints several.
Every figure Luvo Health publishes — 3 figures, read September 2026
| Figure | What it is | Cycle, in their words | Route | Dose | Read |
|---|---|---|---|---|---|
| $27 | from-price | “/week” | Nasal | Not stated | September 2026 |
| $27 | from-price | “/week” | Oral | Not stated | September 2026 |
| $27 | from-price | “/week” | SubQ | Not stated | September 2026 |
In Luvo Health’s own words
- $27 from-price
The page says: “Starting at $ 27 /week”
Same $27/week figure appears on all three Luvo NAD product pages. FIGURE NOTE: visible.txt splits the amount across lines ('Starting at $' / '27' / '/week'), which collapses to 'Starting at $ 27 /week'; dom.txt shows it unsplit as 'Starting at $27/week'. The figure is recorded normalized as $27.
Read from https://www.luvohealth.com/medications/nad-nasal on September 2026.
- $27 from-price
The page says: “Starting at $ 27 /week”
Oral drops. The page's own words are 'NAD+ Drops' and the FAQ headings 'How often do I take it?' and 'Should I take it with food?', i.e. oral administration - but the taxonomy's oral bucket is 'oral-precursor (NMN / NR)' and this page names the molecule as NAD+, so route is left 'unspecified' for the reviewed pass to decide. Same $27/week figure as the spray and the injection. FIGURE NOTE: visible.txt splits the amount across lines ('Starting at $' / '27' / '/week'), which collapses to 'Starting at $ 27 /week'; dom.txt shows it unsplit as 'Starting at $27/week'. The figure is recorded normalized as $27.
Read from https://www.luvohealth.com/medications/nad-liquid-drops-oral on September 2026.
- $27 from-price
The page says: “Starting at $ 27 /week”
Self-administered injection: the FAQ asks 'Where do I inject it?' and 'What supplies are included?'. The page never writes subcutaneous vs intramuscular. Same $27/week figure as the spray and the drops. FIGURE NOTE: visible.txt splits the amount across lines ('Starting at $' / '27' / '/week'), which collapses to 'Starting at $ 27 /week'; dom.txt shows it unsplit as 'Starting at $27/week'. The figure is recorded normalized as $27.
Read from https://www.luvohealth.com/medications/nad-injection on September 2026.
Price disclosure score: 61 of 100
This scores what Luvo Health publishes about its price, and nothing else. It is not a rating of the product, the clinic, the prescriber or the value — this site has read a price page, not used a product. Across all 106 sellers in the index the scores run from 6 to 100, with a median of 72. Luvo Health sits 81 of 106.
| What is scored | What Luvo Health publishes | Points |
|---|---|---|
| An exact figure | The published figure is a floor — a “from” or “starting at” number, which is the bottom of a range and not necessarily a price anyone is charged. | 6of 30 |
| A stated cadence | The seller states the interval it bills on, so a reader knows when the next charge lands. | 20of 20 |
| Visible on the page | Every headline figure (3 figures) is printed where a reader can see it. | 20of 20 |
| A stated route | The seller states how the product is administered, in its own sentence. | 15of 15 |
| A stated dose | None of this seller's 3 figures states a dose, so no cost per milligram can be worked out from the page. | 0of 15 |
| Price disclosure score | This scores what the seller publishes about its price — not the product, the clinic, the prescriber or the value. | 61of 100 |
What Luvo Health does not publish
Each of these is a count over what was actually read, not an impression. 3 figures were read from this seller, and every sentence below is measured against that number.
- None of the 3 figures read from this seller is a standing rate charged by the calendar month.
- No dose is stated beside any of the 3 figures, so nothing on the page divides into a cost per milligram.
Figures visible to a reader on the seller’s page
3 of 3
Figures stating a dose
0 of 3
Figures that resolve to a usable price
3 of 3
Source: Counted over the 3 figures read from Luvo Health’s own pages, September 2026. Each track is that figure count.
Where Luvo Health sits
68 other sellers in this index also state a Nasal and Oral and SubQ route. Ranked with them on price disclosure, Luvo Health is 58 of 69. That is a statement about how completely each one publishes a price, and about nothing else — the figures behind those rows are different kinds of number and several of them state no dose, so they are not a like-for- like price comparison and this site does not present them as one.
Boards Luvo Health appears on
The reading record
This site has read Luvo Health once, in September 2026. A movement can only be shown between two readings taken here, so there is nothing to show yet — and a single reading is a fact about this site's record, never a statement that the seller held its price.
Figures are read from Luvo Health’s own public pages and recorded with the date. What counts as a price, and why a “from” figure is recorded as a floor rather than a rate, is set out on the editorial policy page. Prices in this category move quietly, so the figure above is what the page said on September 2026 and not a promise about today.